Cytokines and Inflammatory Bowel Disease
Description: Project Narrative The present competitive renewal application will focus on two TNF superfamily members and their receptors, TL1A/DR3 and TWEAK/Fn14, for which increasing evidence suggests a major role in the pathogenesis of human and experimental Crohn¿s disease. The proposal will test the novel hypothesis that TL1A/DR3 and TWEAK/Fn14 play a protective role in normal gut homeostasis and in early disease compared to a proinflammatory role in the chronic phase of ileitis. The overall objective of this proposal is to investigate novel cytokine-based therapeutic strategies aimed at treating patients with IBD and begin to develop a cure for this devastating disease.
Funding type: research
Funder scheme: R56
Start date: 2010-08-15
End date: 2011-07-31
Investigator: FABIO COMINELLI
Institution: CASE WESTERN RESERVE UNIVERSITY
Topic: NF-κB Signaling Pathways
Subfield: Cancer Research
Domain: Life Sciences
Funded outputs count: 53
Funder award ID: R56DK042191
OpenAlex ID: G4862219782
